average annual topline growth
of ARCHIMED companies.


people employed
by ARCHIMED companies.

ARCHIMED is focused on accelerating the development of healthcare industries and solutions to the benefit of people and patients around the world.

Read More

Go to

Latest CEO Testimonial


Maurice Gaubatz

Chief Business Officer of ImaBiotech Group

Listen to more podcasts

ARCHIMED funds healthcare industries globally.

ARCHIMED funds healthcare entrepreneurs’ ambitions while the EURÊKA Foundation funds charitable research programs on unmet medical needs.

€10M to 1B

investment size.
Through its discretionary funds, ARCHIMED invests between 10 million and 1 billion euros in leading companies.


managed assets.
ARCHIMED’s managed funds represent more than 6 billion euros of commitments.


ARCHIMED’s MedSeg is split into more than 400 sub-sectors, individually assessed by sector and Impact teams, and consequently prioritized in terms of investment focus.


Our Latest Investment

PlasmidFactory is the leading contract manufacturer and service provider for plasmid and minicircle DNA. The company develops and manufactures exceptionally high-grade plasmids, a key component for the production of mRNA COVID-19 vaccines.

ARCHIMED’s team supports healthcare entrepreneurs to accelerate their company’s development.


Read more

ARCHIMED’s team supports the business development efforts of healthcare companies as well as helping vulnerable people to return to social and professional life.


average annual topline growth
of ARCHIMED companies.


growth rate.
ARCHIMED is accelerating companies growth rate by more than 60% compared to pre-ARCHIMED performance.


healthcare sectors.
ARCHIMED invests globally across 7 prioritized healthcare sectors.


Our Latest Exit

Founded in 1985 near Milan (Italy), Bomi Group is a Medtech and Pharma services provider offering highly skilled logistics services. Bomi has enjoyed significant historical growth and today offers cutting edge transport, warehousing and supply chain management services for healthcare companies.

ARCHIMED delivers superior returns to investors, and to society through the EURÊKA Foundation.

ARCHIMED provides superior returns to investors, allowing people a better life through their pensions and with more fruitful savings – 5% of ARCHIMED’s profit from carried interest is returned to the community through EURÊKA, ARCHIMED’s charitable foundation.



Top decile performers.
ARCHIMED’s first three funds MED I (2014), MED II (2018) and MED Platform I (2019) are at least top decile performers.


All ARCHIMED team members
benefit from carried interest (fund-based long-term incentive plan).

Art. 9

that have sustainable investment as their objective.

Our Latest Project

The EURÊKA Foundation actively supports the global development of Clubhouse, an operator of non-medicalized day houses for the support of people with severe mental issues.